., Nizamuddin. “Effect of SGLT2 Inhibitor (Empagliflozin) on HbA1c in Most Prevalent Age Group of Type 2 Diabetic Patients”. International Journal of Pathology, translated byFahad Naim et al., vol. 20, no. 4, Mar. 2023, pp. 178-81, https://jpathology.com/index.php/OJS/article/view/802.